Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

676
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
676

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Association between aortic wall thrombus and stroke among patients undergoing transfemoral aortic valve replacement.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Outcomes of Patients With High-Risk Plaques Treated With a Bioresorbable Magnesium Scaffold: Insights From the BIOMAG-I Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

The Impact of COVID-19 Infection and Vaccination on Myocarditis Incidence: A Comparative Analysis of Pre-, Peri-, and Post-Pandemic Eras.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Safety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial.

European journal of heart failure·2026
Same author

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Circulation. Cardiovascular interventions·2026

Related Experiment Video

Updated: Jan 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Low- Versus High-capacity Impella for CS After AMI: A Systematic Review and Pooled Data Analysis.

Dan Haberman1, Beni Verma1, Waiel Abusnina1

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, USA.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|January 8, 2026
PubMed
Summary

High-capacity Impella devices show improved survival and fewer complications for acute myocardial infarction with cardiogenic shock (AMI-CS) patients compared to low-capacity devices. Early consideration of high-capacity Impella may enhance treatment outcomes.

More Related Videos

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

24.3K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K

Related Experiment Videos

Last Updated: Jan 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

24.3K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Research

Background:

  • Acute myocardial infarction with cardiogenic shock (AMI-CS) has a high mortality rate.
  • The Impella device offers hemodynamic support with minimal invasiveness.

Purpose of the Study:

  • To compare the effectiveness and safety of low-capacity versus high-capacity Impella devices in AMI-CS patients.
  • To determine the optimal Impella configuration for treating AMI-CS.

Main Methods:

  • A systematic review and pooled analysis of 20 studies involving 3896 AMI-CS patients.
  • Comparison of high-capacity (Impella 5.0/5.5) versus low-capacity (Impella 2.5/CP) devices.
  • Primary outcome: in-hospital or 30-day mortality. Secondary outcomes: mortality on support, ischemic/bleeding complications, AKI requiring RRT, hemolysis.

Main Results:

  • High-capacity Impella was associated with lower in-hospital/30-day mortality (41.4% vs. 45.4%) and mortality on support (17.9% vs. 46.1%).
  • Fewer major bleeding events (1.4% vs. 6.0%) and ischemic complications (3.9% vs. 5.9%) were observed with high-capacity Impella.
  • Higher transfusion requirements were noted with high-capacity Impella (52.1% vs. 23.1%); no significant differences in stroke or AKI requiring RRT.

Conclusions:

  • High-capacity Impella may offer superior survival benefits and reduced complication rates in AMI-CS patients.
  • Findings suggest lower rates of ischemic and major bleeding events with high-capacity Impella.
  • Early consideration of high-capacity Impella in treatment algorithms is supported.